Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. - Wikidata - wikimedia - TriplyDB

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

http://www.wikidata.org/entity/Q30414919

about

ImmunoChip study implicates antigen presentation to T cells in narcolepsy Vaccinology in the third millennium: scientific and social challenges Can Digital Tools Be Used for Improving Immunization Programs?Unmet needs of patients with narcolepsy: perspectives on emerging treatment options The sleepy teenager - diagnostic challenges Narcolepsy: neural mechanisms of sleepiness and cataplexy REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology Targeted vaccine selection in influenza vaccination A qualitative study of the coverage of influenza vaccination on Dutch news sites and social media websites National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013.Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.Narcolepsy as an immune-mediated disease History of narcolepsy at Stanford University.Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England.The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation.Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.Incidence of Narcolepsy in Germany Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection Pandemrix™ and narcolepsy: A critical appraisal of the observational studies.Refining the approach to vaccines against influenza A viruses with pandemic potential.Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy.Laser vaccine adjuvants. History, progress, and potential Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.Influenza-associated neurological complications.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.

P2860

Q23936601-9A9C65E3-6383-402A-A6D4-D0FC85CB4923 Q24261399-D886E61A-2B65-4B08-BD1E-88E3F0B73CAD Q26750836-9F3BFA6A-1083-469A-90C8-510FC872E45B Q26827736-8BE36F9A-E695-47C7-8890-5296A0DC4F04 Q26828570-B4213DE5-88CC-4BEF-9D93-DE6672821E73 Q27004322-A7B85F7B-4B14-4218-9F41-71EE66B6E892 Q27013653-250C5956-A179-4F2C-AAC6-05437ADD17EB Q27030899-293FFFF4-68DC-4D31-9DE7-4702A218416C Q28681524-8FF8420A-A04B-4BDC-A185-3BF198C58BA4 Q28709580-B38AF280-FDC5-44F5-8130-E3008971C580 Q28730881-19AD7342-CD2A-4080-93FC-F9E07B00DB59 Q28943299-AACE5D8B-024F-4130-B3AF-80805D7DB392 Q30204573-E4F6221B-062A-4245-BE3A-BAF9D5CDC48E Q30210097-4703CC64-3921-4037-B1C9-C166C85CA877 Q30352315-86CD2C15-ACEE-4B77-A4A6-76A679CE71EC Q30352329-A1A20B08-03F6-4637-A26E-163FD6E4F498 Q30352889-2B583AEF-365C-4177-A13A-BF84E0CF759C Q30354181-9525E15E-BB1A-45D4-8EB1-DE96E819314A Q30358954-73E273A6-FB7F-419B-BD9F-3C054F24B777 Q30359247-3729EEEF-261A-4A84-A2E3-C83CCF490CCD Q30362536-CC6B800B-BE8C-4730-8D6F-6E74DF3222D6 Q30364889-3889BF0D-78BA-4FA2-873E-7BF364F17C7D Q30364998-EF49FAC3-13FC-403C-9FEB-432F19919893 Q30367259-6ED28E11-3480-4A98-90DE-72360BC0EA50 Q30369654-DF9CC53E-0CD8-4D11-943D-3FF7BD046331 Q30370632-76D75732-2DF0-453B-BA73-67F93F63E980 Q30371742-41E6C993-A9BB-437E-925C-F7A619A75C3C Q30374045-0C9C97F5-9309-45A5-8B2C-234B13604A16 Q30375856-45489CB6-3FAC-454F-B2CF-33511F97D50B Q30376254-98C14FF7-6856-4E43-9C6C-3DC48DA74966 Q30376743-1D9CDE86-DA47-46A4-B32C-E026CCB01BE3 Q30377381-B57B9A52-E307-4D75-A15A-A6E44FE46017 Q30379224-D39B4025-8939-494C-B311-50C8B0E7AA28 Q30381595-65AE1936-0146-4E41-8C23-A0195A8A543D Q30384711-F47D8211-35D0-416D-BE15-B31802793163 Q30413501-46630B47-8F5F-41FD-9B58-F5D2AD889DC0 Q30419146-B5571099-62B0-482F-8FFA-F951084691E3 Q30421549-44EE986E-4504-4581-AA4A-9013A10DF616 Q30423370-C04C6BC1-4ED0-47D7-9635-4E62FA9BBCDE Q30424161-9B73CCA6-3691-4EF4-A0FD-E9FC10EE6DAE

P2860

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

http://www.wikidata.org/entity/Q30414919

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Increased incidence and clinic ...... ccination campaign in Finland.

@ast

Increased incidence and clinic ...... ccination campaign in Finland.

@en

type

label

Increased incidence and clinic ...... ccination campaign in Finland.

@ast

Increased incidence and clinic ...... ccination campaign in Finland.

@en

prefLabel

Increased incidence and clinic ...... ccination campaign in Finland.

@ast

Increased incidence and clinic ...... ccination campaign in Finland.

@en

P1433

Q30414919-2AD42A8B-A4DD-4FA7-A531-0449F3A2B2EE

P1476

Q30414919-FF2E2D00-A9B4-40F0-A3CC-135FE5EB0C45

P2093

Q30414919-2A7F7807-AB68-4C06-81FB-291CC84D9024

Q30414919-389A6D5E-BE7C-4CF4-A620-DF07AC6E9787

Q30414919-516C4FEA-C190-4F7D-9F55-7B75C1004F6B

Q30414919-573A7934-763A-41FD-8ECB-858B8355B122

Q30414919-5B9D62F5-903A-470B-AA92-9282A809CD83

Q30414919-5D1D9A32-9741-4D15-BEB9-3A5108A58311

Q30414919-6B29A08C-1555-4685-85F9-D21F8CA4E64C

Q30414919-7BDBB14A-7165-4455-8026-95A2491E8A0E

Q30414919-7D6FFFC1-66B0-4699-8EEE-3561595AF689

Q30414919-860CFBFB-DDA1-4C3F-809D-746A8355B710

P2860

Q30414919-0E5623E2-2D61-452F-8409-DBCF89B0390B

Q30414919-102C78E9-D0C9-46F3-A2C9-529982DF941A

Q30414919-1F80BFB5-7134-41BC-AC1D-E5719FF52B01

Q30414919-2387E34D-5BCD-4BC1-B44A-4259F4EB5FF9

Q30414919-2771CEFD-DF26-4E1F-84D3-B7E201AB7B3F

Q30414919-380026A3-274D-4543-A7FC-8AA9582503D4

Q30414919-3F531B6E-7F33-4DCD-AAA6-24FCA92A5DDE

Q30414919-41F4B459-744F-46E5-B283-E1C505FBF3B6

Q30414919-429F6CA7-11D8-4069-BC63-31AF52DA9937

Q30414919-4606D87A-28AE-476E-92EF-4D84BD7D1C8B

P304

Q30414919-65C1678E-B6AB-4140-9654-4DEA304172BF

P31

Q30414919-7AFDDDDF-498F-4698-B581-EA183FE9FB9D

P356

Q30414919-9DC63707-A841-4AF7-A9A3-49242C2D3B2E

P407

Q30414919-7F41F32C-F8FD-4B26-AD1C-3552621E3A6A

P433

Q30414919-7E20446B-F6A4-47DB-9859-E1C9F46FC13F

P478

Q30414919-B07A110B-3208-40F8-B496-C3B65A1D6E44

P50

Q30414919-BBC4B8FD-C9EE-4921-B88F-99AEDCD1E09D

Q30414919-C11F1293-0721-4BCC-AC37-685D253097B6

P577

Q30414919-E3CCE7B2-AF15-45F4-AE6A-B9718D777841

P5875

Q30414919-06752995-BAA2-4522-AD3D-BCF318B4F145

P698

Q30414919-B1BD940D-E01A-4E2B-9839-906DF72977DD

P921

Q30414919-0BAD1938-D32B-4712-AA61-88948DD2FB01

Q30414919-5065981F-27B5-445C-B465-3FCD744ACF57

Q30414919-5A1B9266-AECA-40B3-90F4-0B5E1AA505E0

P932

Q30414919-CF2FD178-AAC8-4B10-A27C-D809766823FD

P356

JOURNAL.PONE.0033723

P1433

P1476

Increased incidence and clinic ...... ccination campaign in Finland.

@en

P2093

Christer Hublin

http://www.w3.org/2001/XMLSchema#string

Harri Arikka

http://www.w3.org/2001/XMLSchema#string

Harri Rusanen

http://www.w3.org/2001/XMLSchema#string

Heli Sätilä

http://www.w3.org/2001/XMLSchema#string

Ismo Ilveskoski

http://www.w3.org/2001/XMLSchema#string

Jan Olme

http://www.w3.org/2001/XMLSchema#string

Merimaaria Espo

http://www.w3.org/2001/XMLSchema#string

Miika Linna

http://www.w3.org/2001/XMLSchema#string

Outi Saarenpää-Heikkilä

http://www.w3.org/2001/XMLSchema#string

Pekka Kaipainen

http://www.w3.org/2001/XMLSchema#string

P2860

Narcolepsy is strongly associated with the T-cell receptor alpha locus

An approach based on a genome-wide association study reveals candidate loci for narcolepsy

Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

The effect of infections on susceptibility to autoimmune and allergic diseases

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy.

Safety of pandemic H1N1 vaccines in children and adolescents.

P304

e33723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0033723

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Markku Partinen

P577

2012-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223983051

http://www.w3.org/2001/XMLSchema#string

P698

22470463

http://www.w3.org/2001/XMLSchema#string

P921

P932

3314680

http://www.w3.org/2001/XMLSchema#string